Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127733531 | 12773353 | 1 | I | 2016 | 20160915 | 20160922 | 20160922 | EXP | US-MYLANLABS-2016M1039988 | MYLAN | 0.00 | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127733531 | 12773353 | 1 | PS | CLONIDINE TRANSDERMAL SYSTEM | CLONIDINE | 1 | Transdermal | 0.3 MG, QD, CHANGE QWEEK | 615131 | 76166 | .3 | MG | TRANSDERMAL PATCH | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127733531 | 12773353 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127733531 | 12773353 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127733531 | 12773353 | Back pain | |
| 127733531 | 12773353 | Confusional state | |
| 127733531 | 12773353 | Drug ineffective | |
| 127733531 | 12773353 | Dysphemia | |
| 127733531 | 12773353 | Emotional disorder | |
| 127733531 | 12773353 | Malaise | |
| 127733531 | 12773353 | Pain | |
| 127733531 | 12773353 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127733531 | 12773353 | 1 | 20160801 | 0 |